PMID- 23590429
OWN - NLM
STAT- MEDLINE
DCOM- 20130917
LR  - 20191210
IS  - 1469-8749 (Electronic)
IS  - 0012-1622 (Linking)
VI  - 55
IP  - 8
DP  - 2013 Aug
TI  - Validity and clinimetric properties of the Spinal Alignment and Range of Motion 
      Measure in children with cerebral palsy.
PG  - 745-50
LID - 10.1111/dmcn.12153 [doi]
AB  - AIM: The aim of this study was to assess the validity, responsiveness, and 
      clinimetric properties of the Spinal Alignment and Range of Motion Measure 
      (SAROMM) in children with cerebral palsy (CP). METHOD: Sixty-two children with CP 
      (40 males, 22 females) with a median age of 3 years and 11 months (range 1-6y) 
      and their caregivers participated in this study. Among the children, 56 had 
      spastic CP while six had non-spastic CP; 53 had bilateral CP, while nine had 
      unilateral limb involvement. Thirty-three children were classified as Gross Motor 
      Function Classification System (GMFCS) levels I to III and 23 as levels IV or V. 
      Fifty-six children (90%) received regular rehabilitation by means of regular 
      physical or occupational therapy (50% once or twice per week and 40% more than 
      two times per week) and six children (10%) received irregular rehabilitation 
      (less than once a week). Construct validity was determined by assessing the 
      strength of the correlation between the spinal alignment SAROMM (SAROMM-SA), the 
      range of motion SAROMM (SAROMM-ROM), and the total SAROMM (SAROMM-total), and 
      construct measures, including the 66-item Gross Motor Function Measure (GMFM-66) 
      and Functional Independence Measures for Children (WeeFIM), at baseline and at 
      6-months follow-up. Responsiveness was examined using effect size. Minimal 
      detectable change (MDC) at the 90% confidence level (MDC90) and minimal 
      clinically important difference (MCID) were analysed. RESULTS: The SAROMM with 
      the GMFM-66 and WeeFIM had fair to good construct validity. The effect size 
      values of all SAROMM scales were 0.24 to 0.48. The MDC90 values and MCID range 
      were 1.43 and 0.47 to 1.67 for the SAROMM-SA, 3.12 and 3.68 to 4.07 for the 
      SAROMM-ROM, and 3.22 and 4.53 to 4.62 for the SAROMM-total. INTERPRETATION: The 
      clinimetric properties of the SAROMM allow clinicians to determine whether a 
      change in SAROMM score represents a clinically meaningful change.
CI  - (c) 2013 Mac Keith Press.
FAU - Chen, Chia-Ling
AU  - Chen CL
AD  - Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital 
      at Linkou, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan. 
      clingchen@gmail.com
FAU - Wu, Katie P H
AU  - Wu KP
FAU - Liu, Wen-Yu
AU  - Liu WY
FAU - Cheng, Hsin-Yi Kathy
AU  - Cheng HY
FAU - Shen, I-Hsuan
AU  - Shen IH
FAU - Lin, Keh-Chung
AU  - Lin KC
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Validation Study
DEP - 20130417
PL  - England
TA  - Dev Med Child Neurol
JT  - Developmental medicine and child neurology
JID - 0006761
SB  - IM
CIN - Dev Med Child Neurol. 2013 Aug;55(8):685-6. PMID: 23590406
MH  - Cerebral Palsy/*diagnosis/physiopathology/rehabilitation
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Infant
MH  - Male
MH  - Motor Skills/physiology
MH  - Neuropsychological Tests/*standards
MH  - Psychometrics/*instrumentation
MH  - Range of Motion, Articular/*physiology
MH  - Sensitivity and Specificity
MH  - Severity of Illness Index
MH  - Spinal Diseases/*diagnosis
EDAT- 2013/04/18 06:00
MHDA- 2013/09/18 06:00
CRDT- 2013/04/18 06:00
PHST- 2013/02/26 00:00 [accepted]
PHST- 2013/04/18 06:00 [entrez]
PHST- 2013/04/18 06:00 [pubmed]
PHST- 2013/09/18 06:00 [medline]
AID - 10.1111/dmcn.12153 [doi]
PST - ppublish
SO  - Dev Med Child Neurol. 2013 Aug;55(8):745-50. doi: 10.1111/dmcn.12153. Epub 2013 
      Apr 17.